63010-021 : Rescriptor 200 mg Oral Tablet


NDC: 63010-021
Labeler: Pharmacia and Upjohn Company
Drug Name:  Rescriptor
Rev. Date: 


Appearance:


Markings: RESCRIPTOR;200;mg
Shapes:  Oval
Colors:  White
Size (mm): 17
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

RESCRIPTOR 200 mg: (63010-021) Rescriptor 200 mg Oral Tablet by Pharmacia and Upjohn Company
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 63010-021-18: 180 TABLET IN 1 BOTTLE (63010‑021‑18)

Active Ingredients:

  • Delavirdine Mesylate

Dosage Strength:

  • 200 mg

Inactive Ingredients:

  • Lactose
  • Microcrystalline Cellulose
  • Croscarmellose Sodium
  • Magnesium Stearate
  • Colloidal Silicon Dioxide
  • Carnauba Wax
  • Hypromellose
  • Opadry White Ys-1-18202-a
  • Pharmaceutical Ink Black

Pharmaceutical Classes:

  • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Non-Nucleoside Analog [Chemical/Ingredient]
  • Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 63010-020 Rescriptor 100 mg Oral Tablet by Pharmacia and Upjohn Company
  • 0179-0096 Rescriptor 200 mg Oral Tablet by Kaiser Foundation Hospitals
  • 49702-209 Rescriptor 100 mg Oral Tablet by Viiv Healthcare Company
  • 49702-210 Rescriptor 200 mg Oral Tablet by Viiv Healthcare Company
  • 49702-225 Rescriptor 200 mg Oral Tablet by Viiv Healthcare Company

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63010-021 QR Code

< Prev: 63010-020Next: 63010-027 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.